Urinary 9α,11β-prostaglandin F2 in children with atopic eczema/dermatitis syndrome: An indicator of mast cell activation?

Acta Dermato-Venereologica

Volumn 84, Issue 5, 2004, Pages 359-362

  Øymar, Knut ^a,b   Aksnes, Lage ^b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Atopy; Mast cells; Prostaglandins; Urine

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; ALLERGEN; PROSTAGLANDIN F2 ALPHA;

ARTICLE; ATOPIC DERMATITIS; ATOPY; CELL ACTIVATION; CONTROLLED STUDY; DERMATITIS; DISEASE EXACERBATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; MAST CELL ACTIVATION; PRESCHOOL CHILD; PRIORITY JOURNAL; URINALYSIS; CHILD; HOSPITALIZATION; IMMUNOLOGY; INFANT; URINE;

CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DINOPROST; FEMALE; HUMANS; INFANT; MALE; MAST CELLS; SEVERITY OF ILLNESS INDEX;

EID: 4744353660     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410035515     Document Type: Article

References (20)

1. Williams H, Robertson C, Stewart A, Aït Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of atopic eczema in the international study of asthma and allergy in childhood. J Allergy Clin Immunol 1999; 103: 125-138.
2. Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999; 104: S99-S108.
3. Leiferman KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 1994; 94: 1310-1317.
4. Wollenberg A, Bieber T. Atopic dermatitis from the genes to skin lesions. Allergy 2000; 55: 205-213.
5. O'Sullivan S. On the role of PGD2 metabolites as markers of mast cell activation in asthma. Acta Physiol Scand Suppl 1999; 644: 1-74.
6. O'Sullivan S, Mueller MJ, Dahlen SE, Kumlin M. Analyses of prostaglandin D2 metabolites in urine: comparison between enzyme immunoassay and negative ion chemical ionisation gas chromatography-mass spectrometry. Prostaglandins Other Lipid Mediat 1999; 57: 149-165.
7. O'Sullivan S, Dahlen B, Roquet A, Larsson L, Dahlen SE, Kumlin M. Urinary 9 alpha, 11 beta-PGF2 as a marker of mast cell activation in allergic and aspirin-intolerant asthma. Adv Exp Med Biol 1997; 433: 159-162.
8. O'Sullivan S, Roquet A, Dahlen B, Larsen F, Eklund A, Kumlin M, et al. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J 1998; 12: 345-350.
9. O'Sullivan S, Roquet A, Dahlen B, Dahlen S, Kumlin M. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998; 28: 1332-1339.
10. Nagakura T, Obata T, Shichijo K, Matsuda S, Sigimoto H, Yamashita K, et al. GC/MS analysis of urinary excretion of 9alpha,11beta-PGF2 in acute and exercise-induced asthma in children. Clin Exp Allergy 1998; 28: 181-186.
11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl 1980; 92: 44-47.
12. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl 1989; 144: 13-14.
13. Øymar K, Bjerknes R. Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity. Allergy 2000; 55: 964-968.
14. Sugiura H, Uehara M. Mitosis of mast cells in skin lesions of atopic dermatitis. Acta Derm Venereol 1993; 73: 296-299.
15. Kapp A. Atopic dermatitis - the skin manifestation of atopy. Clin Exp Allergy 1995; 25: 210-219.
16. Böhme M, Wickman M, Nordvall L, Svartengren M, Wahlgren CF. Family history and risk of atopy in children up to 4 years. Clin Exp Allergy 2003; 33: 1226-1231.
17. Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzel S, et al. T cells and T-cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999; 113: 628-634.
18. Obara W, Kawa Y, Ra C, Nishioka K, Soma Y, Mizoguchi M. T cells and mast cells as a major source of interleukin-13 in atopic dermatitis. Dermatology 2002; 205: 11-17.
19. Cottin V, Deviller P, Tardy F, Cordier JF. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo. J Allergy Clin Immunol 1998; 101: 116-123.
20. Kumlin M. Measurements of leukotrienes in the urine. Strategies and applications. Allergy 1997; 52: 124-135.